The Evidence for the Spread and Seeding Capacities of the Mutant Huntingtin Protein in in Vitro Systems and Their Therapeutic Implications

Abounit, , Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes, EMBO J., 35, 2120, 10.15252/embj.201593411

Abounit, , Tunneling nanotubes: a possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases, Prion, 10, 344, 10.1080/19336896.2016.1223003

Abounit, 2012, Wiring through tunneling nanotubes–from electrical signals to organelle transfer, J. Cell Sci., 125, 1089, 10.1242/jcs.083279

Angot, 2012, Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo, PLoS ONE, 7, e39465, 10.1371/journal.pone.0039465

Babcock, 2015, Transcellular spreading of huntingtin aggregates in the Drosophila brain, Proc. Natl. Acad. Sci. U.S.A., 112, E5427, 10.1073/pnas.1516217112

Bohil, 2006, Myosin-X is a molecular motor that functions in filopodia formation, Proc. Natl. Acad. Sci. U.S.A., 103, 12411, 10.1073/pnas.0602443103

Brahic, 2016, Axonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1, Acta Neuropathol., 131, 539, 10.1007/s00401-016-1538-0

Brundin, 2010, Prion-like transmission of protein aggregates in neurodegenerative diseases, Nat. Rev. Mol. Cell Biol., 11, 301, 10.1038/nrm2873

Bukoreshtliev, 2009, Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells, FEBS Lett., 583, 1481, 10.1016/j.febslet.2009.03.065

Busch, 2003, Mutant Huntingtin Promotes the Fibrillogenesis of Wild-type Huntingtin a potential mechanism for loss of huntingtin function in huntington's disease, J. Biol. Chem., 278, 41452, 10.1074/jbc.M303354200

Carroll, 2015, Treating the whole body in Huntington's disease, Lancet Neurol., 14, 1135, 10.1016/S1474-4422(15)00177-5

Cicchetti, 2014, Mutant huntingtin is present in neuronal grafts in Huntington disease patients, Ann. Neurol., 76, 31, 10.1002/ana.24174

Clifford, 2002, Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease, Neuroscience, 109, 81, 10.1016/S0306-4522(01)00409-2

Costanzo, 2013, Transfer of polyglutamine aggregates in neuronal cells occurs in tunneling nanotubes, J. Cell Sci., 126, 3678, 10.1242/jcs.126086

de Calignon, 2012, Propagation of tau pathology in a model of early Alzheimer's disease, Neuron, 73, 685, 10.1016/j.neuron.2011.11.033

Desplats, 2009, Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein, Proc. Natl. Acad. Sci. U.S.A., 106, 13010, 10.1073/pnas.0903691106

Dong, 2012, Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration, J. Gene Med., 14, 468, 10.1002/jgm.2641

Drouin-Ouellet, 2015, Cerebrovascular and blood-brain barrier impairments in Huntington's disease: potential implications for its pathophysiology, Ann. Neurol., 78, 160, 10.1002/ana.24406

Flach, 2012, Tau oligomers impair artificial membrane integrity and cellular viability, J. Biol. Chem., 287, 43223, 10.1074/jbc.M112.396176

Fontaine, 2016, DnaJ/Hsc70 chaperone complexes control the extracellular release of neurodegenerative-associated proteins, EMBO J., 35, 1537, 10.15252/embj.201593489

Freundt, 2012, Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport, Ann. Neurol., 72, 517, 10.1002/ana.23747

Games, 2014, Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in parkinson's disease-like models, J. Neurosci., 34, 9441, 10.1523/JNEUROSCI.5314-13.2014

Goedert, 2010, The propagation of prion-like protein inclusions in neurodegenerative diseases, Trends Neurosci., 33, 317, 10.1016/j.tins.2010.04.003

Goehler, 2010, Pathogenic polyglutamine tracts are potent inducers of spontaneous Sup35 and Rnq1 amyloidogenesis, PLoS ONE, 5, e9642, 10.1371/journal.pone.0009642

Gousset, 2013, Myo10 is a key regulator of TNT formation in neuronal cells, J. Cell Sci., 126, 4424, 10.1242/jcs.129239

Gousset, 2009, Prions hijack tunnelling nanotubes for intercellular spread, Nat. Cell Biol., 11, 328, 10.1038/ncb1841

Guo, 2014, Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases, Nat. Med., 20, 130, 10.1038/nm.3457

Gurke, 2008, The art of cellular communication: tunneling nanotubes bridge the divide, Histochem. Cell Biol., 129, 539, 10.1007/s00418-008-0412-0

Hansen, 2011, α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells, J. Clin. Invest., 121, 715, 10.1172/JCI43366

Hase, 2009, M-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complex, Nat. Cell Biol., 11, 1427, 10.1038/ncb1990

Herrera, 2011, Visualization of cell-to-cell transmission of mutant huntingtin oligomers, PLoS Curr., 3, RRN1210, 10.1371/currents.RRN1210

Holmes, 2013, Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds, Proc. Natl. Acad. Sci. U.S.A., 110, E3138, 10.1073/pnas.1301440110

Jeon, 2016, Human-to-mouse prion-like propagation of mutant huntingtin protein, Acta Neuropathol., 132, 577, 10.1007/s00401-016-1582-9

Jucker, 2013, Self-propagation of pathogenic protein aggregates in neurodegenerative diseases, Nature, 501, 45, 10.1038/nature12481

Kawashima, 2010, Effects of eicosapentaenoic acid on synaptic plasticity, fatty acid profile and phosphoinositide 3-kinase signaling in rat hippocampus and differentiated PC12 cells, J. Nutr. Biochem., 21, 268, 10.1016/j.jnutbio.2008.12.015

Kazantsev, 1999, Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells, Proc. Natl. Acad. Sci. U.S.A., 96, 11404, 10.1073/pnas.96.20.11404

Kegel, 2000, Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy, J. Neurosci. Off. J. Soc. Neurosci., 20, 7268, 10.1523/JNEUROSCI.20-19-07268.2000

Kegel, 2005, Huntingtin associates with acidic phospholipids at the plasma membrane, J. Biol. Chem., 280, 36464, 10.1074/jbc.M503672200

Kegel, 2009, Polyglutamine expansion in huntingtin increases its insertion into lipid bilayers, Biochem. Biophys. Res. Commun., 387, 472, 10.1016/j.bbrc.2009.07.039

Kordower, 2008, Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease, Nat. Med., 14, 504, 10.1038/nm1747

Lee, 2008, Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein, Int. J. Biochem. Cell Biol., 40, 1835, 10.1016/j.biocel.2008.01.017

Lee, 2012, Accumulation of vesicle-associated human tau in distal dendrites drives degeneration and tau secretion in an in situ cellular tauopathy model, Int. J. Alzheimer's Dis., 2012, 172837, 10.1155/2012/172837

Li, 2008, Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation, Nat. Med., 14, 501, 10.1038/nm1746

Lu, 2012, “Huntingtin holiday”: progress toward an Antisense Therapy for Huntington's Disease, Neuron, 74, 964, 10.1016/j.neuron.2012.06.001

Luk, , Pathological α-synuclein transmission initiates parkinson-like neurodegeneration in non-transgenic mice, Science, 338, 949, 10.1126/science.1227157

Luk, , Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice, J. Exp. Med., 209, 975, 10.1084/jem.20112457

Marzo, 2012, Multifaceted roles of tunneling nanotubes in intercellular communication, Front. Physiol., 3, 72, 10.3389/fphys.2012.00072

Melentijevic, 2017, C. elegans neurons jettison protein aggregates and mitochondria under neurotoxic stress, Nature, 542, 367, 10.1038/nature21362

Miaczynska, 2008, Mechanisms and functions of endocytosis, J. Cell Biol., 180, 7, 10.1083/jcb.200711073

Monsellier, 2016, α-Synuclein and huntingtin exon 1 amyloid fibrils bind laterally to the cellular membrane, Sci. Rep., 6, 19180, 10.1038/srep19180

Murck, 2007, Ethyl-EPA in Huntington disease: potentially relevant mechanism of action, Brain Res. Bull., 72, 159, 10.1016/j.brainresbull.2006.10.020

Nizhnikov, 2014, Proteomic screening for amyloid proteins, PLOS ONE, 9, e116003, 10.1371/journal.pone.0116003

Oh, 2016, Mesenchymal stem cells inhibit transmission of α-synuclein by modulating clathrin-mediated endocytosis in a parkinsonian model, Cell Rep., 14, 835, 10.1016/j.celrep.2015.12.075

Olanow, 2009, Is Parkinson's disease a prion disorder?, Proc. Natl. Acad. Sci. U.S.A., 106, 12571, 10.1073/pnas.0906759106

Pearce, 2015, Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain, Nat. Commun., 6, 6768, 10.1038/ncomms7768

Pecho-Vrieseling, 2014, Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons, Nat. Neurosci., 17, 1064, 10.1038/nn.3761

Pieri, 2012, Fibrillar α-synuclein and huntingtin exon 1 assemblies are toxic to the cells, Biophys. J., 102, 2894, 10.1016/j.bpj.2012.04.050

Proenca, 2013, Atg4b-dependent autophagic flux alleviates huntington's disease progression, PLoS ONE, 8, e68357, 10.1371/journal.pone.0068357

Puri, 2005, Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial, Neurology, 65, 286, 10.1212/01.wnl.0000169025.09670.6d

Ravikumar, 2004, Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease, Nat. Genet., 36, 585, 10.1038/ng1362

Ren, 2009, Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates, Nat. Cell Biol., 11, 219, 10.1038/ncb1830

Rey, 2016, Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease, J. Exp. Med., 213, 1759, 10.1084/jem.20160368

Ruiz-Arlandis, 2016, Binding, internalization and fate of Huntingtin Exon1 fibrillar assemblies in mitotic and nonmitotic neuroblastoma cells, Neuropathol. Appl. Neurobiol., 42, 137, 10.1111/nan.12258

Santini, 2009, Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia, Sci. Signal., 2, ra36, 10.1126/scisignal.2000308

Sassone, 2009, Huntington's disease: the current state of research with peripheral tissues, Exp. Neurol., 219, 385, 10.1016/j.expneurol.2009.05.012

Saudou, 1998, Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions, Cell, 95, 55, 10.1016/S0092-8674(00)81782-1

Serpionov, 2017, Distinct mechanisms of mutant huntingtin toxicity in different yeast strains, FEMS Yeast Res., 17, fow102, 10.1093/femsyr/fow102

Smith, 2011, Active generation and propagation of Ca2+ signals within tunneling membrane nanotubes, Biophys. J., 100, L37, 10.1016/j.bpj.2011.03.007

Smith, 2005, Synaptic dysfunction in Huntington's disease: a new perspective, Cell. Mol. Life Sci., 62, 1901, 10.1007/s00018-005-5084-5

Soto, 2012, Transmissible proteins: expanding the prion heresy, Cell, 149, 968, 10.1016/j.cell.2012.05.007

Spencer, 2017, Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy, Acta Neuropathol. Commun., 5, 7, 10.1186/s40478-016-0410-8

Tan, 2015, Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin, Mol. Psychiatry, 20, 1286, 10.1038/mp.2015.81

Trajkovic, 2017, Mutant huntingtin is secreted via a late endosomal/lysosomal unconventional secretory pathway, J. Neurosci., 37, 9000, 10.1523/JNEUROSCI.0118-17.2017

Trevino, 2012, Fibrillar structure and charge determine the interaction of polyglutamine protein aggregates with the cell surface, J. Biol. Chem., 287, 29722, 10.1074/jbc.M112.372474

Trushina, 2004, Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro, Mol. Cell. Biol., 24, 8195, 10.1128/MCB.24.18.8195-8209.2004

Volpicelli-Daley, 2011, Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death, Neuron, 72, 57, 10.1016/j.neuron.2011.08.033

Wang, 2014, Targeting the mTOR signaling network for Alzheimer's disease therapy, Mol. Neurobiol., 49, 120, 10.1007/s12035-013-8505-8

Wang, 2014, Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease, Nat. Med., 20, 536, 10.1038/nm.3514

Wang, 2011, Tunneling-nanotube development in astrocytes depends on p53 activation, Cell Death Differ., 18, 732, 10.1038/cdd.2010.147

Watkins, 2005, Functional connectivity between immune cells mediated by tunneling nanotubules, Immunity, 23, 309, 10.1016/j.immuni.2005.08.009

Weiss, 2012, Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression, J. Clin. Invest., 122, 3731, 10.1172/JCI64565

Wild, 2015, Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients, J. Clin. Invest., 125, 1979, 10.1172/JCI80743

Wu, 2008, DHA dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition, Neuroscience, 155, 751, 10.1016/j.neuroscience.2008.05.061

Wu, 2013, Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons, J. Biol. Chem., 288, 1856, 10.1074/jbc.M112.394528

Yang, 2017, CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease, J. Clin. Invest., 127, 2719, 10.1172/JCI92087

Yang, 2002, Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells, Hum. Mol. Genet., 11, 2905, 10.1093/hmg/11.23.2905

Zala, 2005, Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment, Neurobiol. Dis., 20, 785, 10.1016/j.nbd.2005.05.017

Zhu, 2003, The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation, J. Biol. Chem., 278, 40186, 10.1074/jbc.M305326200